. Financial Statements The Company’s total assets as of March 31, 2018 was equivalent to Baht 805.54 million which decreased by Baht 7.30 million consisting of current assets of Baht 438.37 million which
Phra Nang Klao-Riverview 5) Lumpini Seaview Cha-am (Building A) 6) The Selected Kaset-Ngamwongwan by L.P.N. 3. Other non-current assets increased 13.35% from 31 December 2017 as a result of the
Increase (Decrease) % Current assets 109.87 111.45 (1.57) (1.41) Land, building and equipment 138.20 149.96 (11.75) (7.84) Assets on long-term lease 71.47 99.17 (27.70) (27.93) Deferred income tax increased
had total asset as of March 31, 2020 with amount of 817.41 million bath increase from December 31, 2019 by 6.50 million baht or 0.80% increased, the details of the change are as follows: 1.1 Current
million due to redemption of debenture in January 2020 in the amount of THB 300 million Trade and Other Current Receivables decreased by THB 159.65 million from those as at December 31, 2019 to THB 87.65
% Change YoY % YoY Assets Cash 159.47 11.6% 214.94 14.1% 55.47 34.8% Current investments 83.07 6.1% 148.34 9.7% 65.27 78.6% Trade & Other receivable 114.24 8.3% 137.32 9.0% 23.08 20.2% Current contract
changes Balance by Quarter Change Q1-22 Q4-21 Q1-22 VS Q4-21 (MB) (MB) % Cash and cash equivalent 1,245.4 378.5 866.9 229.0 Other current financial assets – Unit trust 400.5 720.0 (319.5) (44.4) Trade and
changes Balance by Quarter Change Q2–24 Q4–23 Q2–24 VS Q4–23 (MB) (MB) % Inventories 550.7 720.5 (169.8) (23.6) Other current assets 224.5 269.2 (44.7) (16.6) Total assets 6,576.9 6,581.5 (4.6) (0.1) Assets
international sales declined dramatically at 46.03% compared to the same period of the previous year. One of the issues was the delayed product delivery after the license was issued from China Food and Drug
granted a license from China Food and Drug Administration (CFDA) during the beginning of 2018 as the Company had to redesign and adjust product packaging according to the granted license as well as change